Atlas Trials

A Pharmacokinetic Study of AMG 386 in Cancer Subjects With Normal and Impaired Renal Function

Clinical trial NCT01331941 · COMPLETED

Trial details

NCT number
NCT01331941
Sponsor
Amgen
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Advanced Solid TumorsKidney DiseaseRenal Impairment
Start date
2011-09-19
Primary completion
2013-02-26
Enrollment
35

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.